The following topics concerning menopause risks and benefits may be found in the AMS Information Sheets.
Risks and Benefits of MHT/HRT
Women making decisions about treatment during menopause - or any other medical decisions - are going to be presented with information about risk, for instance the risk of taking hormone therapy (HT). How does a woman know if increased risk is relevant to her? It helps to have a good grasp of the way the terminology is used by doctors and researchers.
Menopausal Treatments and the Risk of Venous Thrombosis/Thromboembolism
Hormone Replacement Therapy (HRT) containing oestrogens in tablet form and also selective oestrogen receptor modulators (See AMS Information Sheet - The Role of SERMS after Menopause) increase the risk of deep vein thrombosis (DVT) (1-6) and pulmonary embolus (PE).
Note: Medical and scientific information provided and endorsed by the Australasian Menopause Society might not be relevant to a particular person's circumstances and should always be discussed with that person's own healthcare provider.
These Information Sheets may contain copyright or otherwise protected material. Reproduction of this Information Sheet by Australasian Menopause Society Members and other health professionals for clinical practice is permissible. Any other use of this information (hardcopy and electronic versions) must be agreed to and approved by the Australasian Menopause Society.
Content updated March 2014